Congress Saves NIH Budget!

Congress: NIH Budget Will Not Be Cut

Congress Inks Spending Deal That Jettisons Trump Priorities

– Bloomberg News, May 1, 2017

U.S. House and Senate negotiators reached a tentative bipartisan deal on a $1.1 trillion spending bill that largely tracks with Democratic priorities and rejects most of President Donald Trump’s wish list.

Overall, the compromise resembles more of an Obama administration-era budget than a Trump one. The National Institutes of Health, for example, would see a $2 billion boost, reflecting the popularity of medical research among lawmakers.

 

Read the whole article on Bloomberg

Powered by CARB-X

Tyler Merkeley, CARB-X co-founder and program director for ASPR’s Biomedical Advanced Research and Development Authority, describes the drivers and next steps in creating a diverse portfolio Powered by CARB-X, one of the world’s largest public-private partnerships dedicated to accelerating development of innovative antibacterial drugs, diagnostics, and devices.

 

 

 

New NIAID Funding Opportunity Announcement: Partnerships for Countermeasures Against Select Pathogens (R01)

Purpose: To solicit research applications for milestone-driven projects focused on preclinical development of lead candidate countermeasures (therapeutics, vaccines and related technologies, or diagnostics) against select NIAID Emerging Infectious Diseases/Pathogens.

Application Due Date: October 3, 2016

Budget: Direct costs of up to $750,000 per year may be requested. Applicants may also request up to an additional $300,000 in the first year of the award for major equipment to ensure that research objectives can be met and biohazards can be contained, totaling $1,050,000 direct costs.

Total Award: ~4,000,000 over 5 years

 

 

To discuss this opportunity or to learn about other non-dilutive funding that may be relevant to your organization, send us a note and we’ll get in touch with you directly!

The National Science Foundation’s FY2016 SBIR and STTR Programs are Open!

Purpose: NSF’s SBIR and STTR programs provide non-dilutive funds for early-stage research and development (R&D) at small businesses. This R&D should be based on innovative, transformational technology with potential for substantial commercial and/or societal benefits. The programs invite proposals from small businesses across a broad range of science and engineering disciplines. For the STTR program, this must be in collaboration with researchers at universities, Federally-Funded Research and Development Centers, and other non-profit institutions.

Application Due Dates:
SBIR Phase I Proposal: June 16, 2016
STTR Phase I Proposal: June 20, 2016

Budget: $225,000 for a 6-12 month development/ feasibility project. You can then compete for a second grant of up to $750,000 over a 2 year period, with the aim of advancing the technology toward commercial deployment.

 

Selected Topics:

Biological Technologies (BT)

  • BT3. Life Sciences Research Tools
  • BT4. Bioinstrumentation
  • BT7. Computational Biology and Bioinformatics
  • BT8. Advanced Biomanufacturing- New Topic
  • BT9. Advanced technologies for functional genomics in organismal systems – New Topic
  • Tissue Engineering and Regenerative Medicine

Smart Health (SH) and Biomedical (BM) Technologies

  • SH1. Business Models for User-Centered Healthcare
  • SH2. Digital Health Information Infrastructure
  • SH3. From Data to Decisions
  • SH4. Interoperability of Health Record Systems, Medical Sensors, Devices and Robotics
  • BM1. Pharmaceutical Manufacturing
  • BM2. Materials for Biomedical Applications
  • BM3. Biomedical Engineering
  • BM4. Noninvasive Imaging of Brain Function
  • BM5. Medical Imaging Technologies
  • BM6. Diagnostic Assays and Platforms
  • BM7. Drug Delivery

 

View the SBIR Phase I Solicitation
View the STTR Phase I Solicitation

 

To discuss these opportunities or to learn about other non-dilutive funding that may be relevant to your organization, send us a note and we’ll get in touch with you directly!